Indigo Paints (INDIGOPNTS) Q1 26/27 earnings summary

Executive summary

• Achieved double-digit revenue and volume growth in Q1 FY27, with standalone revenue up 18.7% YoY and consolidated revenue up 19.7% YoY, outpacing the broader paint sector.

• Margin expansion was driven by operating leverage, disciplined discretionary spending, and timely price increases, despite volatile raw material costs and global supply disruptions.

• PAT margin improved to 11.8% (standalone) and 11.0% (consolidated), with standalone PAT up 60.7% YoY and consolidated PAT up 60% YoY.

• Strategic focus on maximizing dealer network utilization, micro-segmentation, and tailored category strategies contributed to broad-based growth.

• Aggressive top-line growth will be prioritized, with increased investments in trade and influencer engagement planned for Q2.

Financial highlights

• Standalone revenue from operations rose to INR 350 crore (up 18.7% YoY); consolidated revenue (including Apple Chemie) grew to INR 369.7 crore (up 19.7% YoY).

• Standalone EBITDA increased 42% YoY to INR 61.9 crore, with margin rising from 14.8% to 17.7%; consolidated EBITDA up 40% YoY to INR 62 crore at a 16.8% margin.

• Standalone PAT grew 60.7% YoY to INR 42.4 crore; consolidated PAT up 60% YoY to INR 41.7 crore.

• Gross margin for the quarter was 45.3%, maintaining a lead over industry peers despite supply chain disruptions.

• Advertising and promotion spend reduced to 4.3% of revenue from 6.8% YoY, with funds redirected to digital and influencer channels.

Outlook and guidance

• Management expects to accelerate top-line growth in Q2, with increased spending on trade and influencer engagement.

• No significant CapEx anticipated for the next three years as the major investment cycle concludes; incremental revenue expected to drive higher free cash flow.

• Margins may fluctuate due to product mix and raw material volatility, with Q2 typically being seasonally weaker for profitability.

• No concrete margin or growth rate guidance, but a substantial gap over industry growth is targeted.

• Apple Chemie growth momentum expected to continue, with gross margins to improve in Q2 and normalize by Q3 FY27; acquisition of additional 11% stake planned.